Not yet recruiting NCT07743476
Quantitative Marrow Imaging, Marrow Reserve, And Clinical Outcomes In Patients Undergoing Radiotherapy For Hematologic And Related Disorders
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: data collection.
- Who it may be relevant to
- Registry conditions: Quantitative Marrow Imaging, Marrow Reserve, Clinical Outcomes, Radiotherapy. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
To create a registry for people who are undergoing or previously underwent radiotherapy for hematologic or related disorders.
Interventions
- Other data collection
The study will collect clinical, imaging, laboratory, treatment, and outcome data from the electronic medical record, radiation treatment planning systems, imaging archives, and other institutional clinical databases
Primary outcome measures
- Safety and adverse events (AEs). [Time frame: Through study completion; an average of 1 year.]
Eligibility criteria
Inclusion criteria
- Undergoing or previously underwent radiotherapy at The University of Texas MD Anderson Cancer Center for hematologic or related disorders.
- Available clinical, imaging, laboratory, treatment, and/or outcome data relevant to study objectives.
- Ability to provide informed consent for prospective participation, when applicable.
Exclusion criteria
Participants meeting any of the following criteria will be excluded:
- Inability to provide informed consent, or when applicable, the absence of a legally authorized representative able to provide consent for prospective participation.
- Insufficient clinical information available to support study objectives.
- Pregnant women
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- UT MD Anderson Cancer Center — Houston
Identifiers
NCT: NCT07743476 · 2026-0958 · NCI-2026-05811